Zongtai Wu
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis.
Journal: Frontiers in immunology
Published: February 17, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes.
Journal: Therapeutic advances in neurological disorders
Published: November 07, 2024
Initiation response, maximized therapeutic efficacy, and post-treatment effects of biological targeted therapies in myasthenia gravis: a systematic review and network meta-analysis.
Journal: Frontiers in neurology
Published: August 12, 2024
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study.
Journal: Therapeutic advances in neurological disorders
Published: August 06, 2024
Optimal time for the addition of non-corticosteroid immunosuppressants in myasthenia gravis: a single-center retrospective study in China.
Journal: Frontiers in neurology
Published: August 01, 2024
Identification of putative genes for caffeoylated flavonoid glycoside biosynthesis in Pseudognaphalium affine.
Journal: Plant physiology and biochemistry : PPB
Published: July 25, 2024
Nomogram for predicting pregnancy-related relapse of myasthenia gravis.
Journal: Orphanet journal of rare diseases
Published: July 02, 2024
Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study.
Journal: Journal of neuroimmunology
Published: June 19, 2024
An activity-based sensing fluorogenic probe for monitoring O-methyltransferase in plants.
Journal: The New phytologist
Published: April 27, 2024
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.
Journal: Frontiers in immunology
Published: April 16, 2024
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series.
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series.
Journal: Therapeutic advances in neurological disorders
Published: January 03, 2024
Effect of pinoresinol-lariciresinol reductases on biosynthesis of lignans with substrate selectivity in Schisandra chinensis.
Journal: Phytochemistry
Published: November 12, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026